AIMC Topic: Antibodies, Monoclonal

Clear Filters Showing 1 to 10 of 81 articles

Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study.

Cephalalgia : an international journal of headache
BackgroundUnderstanding characteristics and reasons associated with using calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) for migraine prevention may help clinicians individualize treatment plans and achieve better patient outcomes.M...

Leveraging multi-modal feature learning for predictions of antibody viscosity.

mAbs
The shift toward subcutaneous administration for biologic therapeutics has gained momentum due to its patient-friendly nature, convenience, reduced healthcare burden, and improved compliance compared to traditional intravenous infusions. However, a s...

Accelerating mechanistic model calibration in protein chromatography using artificial neural networks.

Journal of chromatography. A
In the manufacturing of therapeutic monoclonal antibodies (mAbs), mechanistic models can aid the evaluation and selection of suitable chromatography operating conditions during process development. However, model calibration remains a common bottlene...

Machine Learning for Predicting the Drug-to-Antibody Ratio (DAR) in the Synthesis of Antibody-Drug Conjugates (ADCs).

Journal of chemical information and modeling
The pharmaceutical industry faces challenges in developing efficient and cost-effective drug delivery systems. Among various applications, antibody-drug conjugates (ADCs) stand out by combining cytotoxic or bioactive agents with monoclonal antibodies...

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with Zr/I-Labeled Tinurilimab.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Lung adenocarcinoma (LUAD) constitutes a major cause of cancer-related fatalities worldwide. Early identification of malignant pulmonary nodules constitutes the most effective approach to reducing the mortality of LUAD. Despite the wide application o...

Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning.

mAbs
Highly concentrated antibody solutions are necessary for developing subcutaneous injections but often exhibit high viscosities, posing challenges in antibody-drug development, manufacturing, and administration. Previous computational models were only...

PROPERMAB: an integrative framework for prediction of antibody developability using machine learning.

mAbs
Selection of lead therapeutic molecules is often driven predominantly by pharmacological efficacy and safety. Candidate developability, such as biophysical properties that affect the formulation of the molecule into a product, is usually evaluated on...

An antibody developability triaging pipeline exploiting protein language models.

mAbs
Therapeutic monoclonal antibodies (mAbs) are a successful class of biologic drugs that are frequently selected from phage display libraries and transgenic mice that produce fully human antibodies. However, binding affinity to the correct epitope is n...

Development of an mPBPK machine learning framework for early target pharmacology assessment of biotherapeutics.

Scientific reports
Development of antibodies often begins with the assessment and optimization of their physicochemical properties, and their efficient engagement with the target of interest. Decisions at the early optimization stage are critical for the success of the...